Baselake reports 5.3% stake in Kezar Life Sciences (NASDAQ: KZR)

NodeGuardian · 2026-04-07T05:17:51+00:00

Baslake-affiliated entities disclosed a 5.3% passive stake in Kezar Life Sciences through a Schedule 13G SEC filing, owning 391,862 shares and indicating a non-activist investment approach.

NodeGuardian

2026-04-07 05:17:51

Abstract generation in progress

Baslake-affiliated parties, including Baselake Partners, LP, Baselake Management, LLC, and David Paolella, have reported a 5.3% passive stake in Kezar Life Sciences (NASDAQ: KZR) through a Schedule 13G SEC filing. This filing indicates beneficial ownership of 391,862 shares with shared voting and dispositive power, based on 7,371,527 shares outstanding as of March 23, 2026. The filing explicitly disclaims activist intent, signifying an institutional/passive investment posture.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.